Reports for NATCO PHARMA (CANADA) INC
Company Name
NATCO PHARMA (CANADA) INC
Totals |
||
Shortage reports |
19 |
|
| Actual shortage: | 4 (21%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 15 (79%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
1 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NATCO-CITALOPRAM | 10MG | TABLET | Resolved | 2018-11-23 | 2019-02-04 | 67518 |
| NAT-DONEPEZIL | 5MG | TABLET | Resolved | 2018-07-13 | 2020-10-26 | 55625 |
| NAT-DONEPEZIL | 10MG | TABLET | Resolved | 2018-07-13 | 2020-10-26 | 55630 |
| NAT-ERLOTINIB | 25MG | TABLET | Actual shortage | 2020-12-03 | 2023-05-03 | 129536 |
| NAT-ERLOTINIB | 100MG | TABLET | Actual shortage | 2020-12-03 | 2023-05-17 | 129550 |
| NAT-ERLOTINIB | 150MG | TABLET | Actual shortage | 2020-12-03 | 2023-05-03 | 129553 |
| NAT-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-02-15 | 2020-10-26 | 75793 |
| NAT-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-02-15 | 2020-10-26 | 75799 |
| NAT-LEVETIRACETAM | 250MG | TABLET | Resolved | 2019-02-15 | 2022-07-01 | 75810 |
| NAT-LEVETIRACETAM | 500MG | TABLET | Resolved | 2018-10-19 | 2020-10-26 | 64878 |
| NAT-LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-04-17 | 2021-10-15 | 81921 |
| NAT-PREGABALIN | 225MG | CAPSULE | Actual shortage | 2023-05-17 | 2023-05-18 | 192650 |
| NAT-QUETIAPINE | 25MG | TABLET | Resolved | 2018-10-31 | 2022-07-01 | 65944 |
| NAT-QUETIAPINE | 100MG | TABLET | Resolved | 2019-04-17 | 2022-07-01 | 81900 |
| NAT-QUETIAPINE | 150MG | TABLET | Resolved | 2019-04-23 | 2021-10-31 | 82236 |
| NAT-QUETIAPINE | 200MG | TABLET | Resolved | 2019-04-17 | 2022-07-01 | 81903 |
| NAT-QUETIAPINE | 300MG | TABLET | Resolved | 2019-04-17 | 2022-07-01 | 81906 |
| NAT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-11-23 | 2019-02-07 | 67512 |
| NAT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-11-23 | 2019-02-07 | 67515 |
Showing 1 to 19 of 19
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0